Advertisement

Oxford University Begins COVID-19 Vaccine Trials for Children & Teenagers

Oxford University has launched clinical trials to test the safety and efficacy of the Coronavirus vaccine co-developed with AstraZeneca on children and teenagers.

Advertisement

According to details, around 240 participants aged 6 to 17 are taking part in the single-blind and randomized trial, making it the youngest group to be tested for the COVID-19 vaccine.


ALSO READ

NASA To Fly a Helicopter On Mars For The First Time Ever


Financed by the UK’s National Institute for Health Research (NIHR), the clinical trials are being held in London, Southampton, and Bristol.

Dr. William Hoff, Chief Executive of NIHR’s Clinical Research Network, has said that “Oxford-AstraZeneca Coronavirus vaccine research contributed in protecting adults and the latest clinical trials will help in protecting children and young adults in the future.”


ALSO READ

NBP Records Highest Ever Profit in 2020


Andrew Pollard, Professor of Paediatric Infection and Immunity, and Chief Investigator on the Oxford-AstraZeneca vaccine trial has noted that “notwithstanding with the fact that most children remain relatively unaffected by Coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children as they will benefit from vaccination.”

Advertisement

Besides Oxford-AstraZeneca, Pfizer, Moderna, and Janssen have also announced plans to start trials to test the safety and efficacy of their vaccines on children and teenagers in the coming months.

Advertisement

Advertisement

See ProPakistani in...
ProPakistani App
close
>